268 related articles for article (PubMed ID: 18783549)
1. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.
Gressner OA; Gressner AM
Liver Int; 2008 Sep; 28(8):1065-79. PubMed ID: 18783549
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
3. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection.
Tache D; Bogdan F; Pisoschi C; Baniţă M; Stănciulescu C; Fusaru AM; Comănescu V
Rom J Morphol Embryol; 2011; 52(1 Suppl):409-12. PubMed ID: 21424084
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
[TBL] [Abstract][Full Text] [Related]
6. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.
Gressner OA; Lahme B; Siluschek M; Gressner AM
Liver Int; 2009 Jul; 29(6):886-97. PubMed ID: 19291178
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis.
Meindl-Beinker NM; Dooley S
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S122-7. PubMed ID: 18336655
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta/connective tissue growth factor axis in the kidney.
Qi W; Chen X; Poronnik P; Pollock CA
Int J Biochem Cell Biol; 2008; 40(1):9-13. PubMed ID: 17300978
[TBL] [Abstract][Full Text] [Related]
11. RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.
Li G; Li D; Xie Q; Shi Y; Jiang S; Jin Y
J Gene Med; 2008 Sep; 10(9):1039-47. PubMed ID: 18613219
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta/Smad signaling in the injured liver.
Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
[TBL] [Abstract][Full Text] [Related]
14. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
Gressner AM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
Abraham D
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v8-9. PubMed ID: 18784153
[TBL] [Abstract][Full Text] [Related]
16. Effect of transforming growth factor-beta1 on expression of the connective tissue growth factor (CCN2/CTGF) gene in normal human gingival fibroblasts and periodontal ligament cells.
Takeuchi H; Kubota S; Murakashi E; Fukada T; Hashimoto S; Takigawa M; Numabe Y
J Periodontal Res; 2009 Apr; 44(2):161-9. PubMed ID: 19210343
[TBL] [Abstract][Full Text] [Related]
17. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor: context-dependent functions and mechanisms of regulation.
Cicha I; Goppelt-Struebe M
Biofactors; 2009; 35(2):200-8. PubMed ID: 19449449
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.
Walter R; Wanninger J; Bauer S; Eisinger K; Neumeier M; Weiss TS; Amann T; Hellerbrand C; Schäffler A; Schölmerich J; Buechler C
Exp Mol Pathol; 2011 Dec; 91(3):740-4. PubMed ID: 21946149
[TBL] [Abstract][Full Text] [Related]
20. Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?
Wang P; Liu T; Cong M; Wu X; Bai Y; Yin C; An W; Wang B; Jia J; You H
Liver Int; 2009 Apr; 29(4):575-84. PubMed ID: 19323784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]